557 related articles for article (PubMed ID: 27268025)
1. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG).
Singh NA; Mandal AK; Khan ZA
Nutr J; 2016 Jun; 15(1):60. PubMed ID: 27268025
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.
Pervin M; Unno K; Ohishi T; Tanabe H; Miyoshi N; Nakamura Y
Molecules; 2018 May; 23(6):. PubMed ID: 29843466
[TBL] [Abstract][Full Text] [Related]
3. Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease.
Xicota L; Rodriguez-Morato J; Dierssen M; de la Torre R
Curr Drug Targets; 2017; 18(2):174-195. PubMed ID: 26302801
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease.
Xu Q; Langley M; Kanthasamy AG; Reddy MB
J Nutr; 2017 Oct; 147(10):1926-1931. PubMed ID: 28835392
[No Abstract] [Full Text] [Related]
5. Tea Polyphenols in Parkinson's Disease.
Caruana M; Vassallo N
Adv Exp Med Biol; 2015; 863():117-37. PubMed ID: 26092629
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-β Drosophila melanogaster.
Martinez-Perez DA; Jimenez-Del-Rio M; Velez-Pardo C
Neurotox Res; 2018 Oct; 34(3):401-416. PubMed ID: 29667128
[TBL] [Abstract][Full Text] [Related]
7. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
Weinreb O; Mandel S; Amit T; Youdim MB
J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases.
Mandel SA; Amit T; Weinreb O; Reznichenko L; Youdim MB
CNS Neurosci Ther; 2008; 14(4):352-65. PubMed ID: 19040558
[TBL] [Abstract][Full Text] [Related]
9. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.
Mandel S; Weinreb O; Amit T; Youdim MB
J Neurochem; 2004 Mar; 88(6):1555-69. PubMed ID: 15009657
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
Zhang S; Zhu Q; Chen JY; OuYang D; Lu JH
Phytomedicine; 2020 Dec; 79():153316. PubMed ID: 32942205
[TBL] [Abstract][Full Text] [Related]
12. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.
Gonçalves PB; Sodero ACR; Cordeiro Y
Biomolecules; 2021 May; 11(5):. PubMed ID: 34065606
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases.
Chen SQ; Wang ZS; Ma YX; Zhang W; Lu JL; Liang YR; Zheng XQ
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495349
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (-)-epigallocatechin-3-gallate.
Srividhya R; Jyothilakshmi V; Arulmathi K; Senthilkumaran V; Kalaiselvi P
Int J Dev Neurosci; 2008 Apr; 26(2):217-23. PubMed ID: 18207349
[TBL] [Abstract][Full Text] [Related]
15. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate.
Kim HS; Quon MJ; Kim JA
Redox Biol; 2014; 2():187-95. PubMed ID: 24494192
[TBL] [Abstract][Full Text] [Related]
16. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG).
Mandel SA; Amit T; Kalfon L; Reznichenko L; Weinreb O; Youdim MB
J Alzheimers Dis; 2008 Oct; 15(2):211-22. PubMed ID: 18953110
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate for Parkinson's disease.
Sergi CM
Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1029-1041. PubMed ID: 35748799
[TBL] [Abstract][Full Text] [Related]
18. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate.
Weinreb O; Amit T; Youdim MB
Free Radic Biol Med; 2007 Aug; 43(4):546-56. PubMed ID: 17640565
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms.
Kumar P; Kumar A
Psychopharmacology (Berl); 2009 Dec; 207(2):257-70. PubMed ID: 19763544
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of a green tea polyphenol, epigallocatechin-3-gallate, against sevoflurane-induced neuronal apoptosis involve regulation of CREB/BDNF/TrkB and PI3K/Akt/mTOR signalling pathways in neonatal mice.
Ding ML; Ma H; Man YG; Lv HY
Can J Physiol Pharmacol; 2017 Dec; 95(12):1396-1405. PubMed ID: 28679060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
